The 1Q20 IPO Market's Law Firm Leaderboard
In the first quarter of 2020, 24 IPOs raised $6.8 billion, up from the 1Q19 by deal count and proceeds. Activity waned in March as the stock market’s sharp sell-off closed the IPO window. Biotechs once again dominated issuance, as health care comprised half of all IPOs. With every IPO requiring at least two legal firms, one for issuers and one for underwriters (and some hiring as many as five), the 1Q20 saw 69 legal engagements (100 including SPACs) with 39 law firms.
View our Report on The Most Active Legal Firms of the 1Q20 IPO Market
To read the entire report, sign up for a free trial of IPO Pro, the platform that gives you all of the IPO information you need, all in one place.
Start a Free Trial of IPO Pro
The article The 1Q20 IPO Market's Law Firm Leaderboard originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Latest IPOs Videos
- Nasdaq’s Head of Healthcare Listings on the State of IPOs During the Coronavirus Pandemic
- Zentalis Pharmaceuticals prices upsized IPO at $18, the high end of the range
- Hot blooded: Keros Therapeutics prices upsized IPO at $16, the high end of the range
- US IPO Week Ahead: Another biotech plans to take on the IPO market